Advances in elderly patients with newly diagnosed multiple myeloma from the 19th European Hematology Association Annual Congress
10.3760/cma.j.issn.1009-9921.2014.07.003
- VernacularTitle:初诊老年多发性骨髓瘤患者研究进展:第19届欧洲血液学会年会报道
- Author:
Wanqiu ZHU
;
Wenming CHEN
- Publication Type:Journal Article
- Keywords:
Multiple myeloma;
Treatment;
Prognosis
- From:
Journal of Leukemia & Lymphoma
2014;23(7):390-392
- CountryChina
- Language:Chinese
-
Abstract:
As the introduction of novel agents,the median overall survival of elderly newly diagnosed multiple myeloma patients has increased roughly from 30 to 60 months.But patients with high risk prognostic features still have a poor clinical outcome.This paper which combined the 19th annual congress of the European Hematology Association (EHA) reviews the advances in elderly patients with newly diagnosed multiple myeloma,including standard of care,the way to treatment and prognostic factors.
